## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.1% below STRENGTH zone (4.0-10.0%); PEG 3.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (34% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($557.65)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. SDA Awards $1.6 Billion in Tranche 3 Tracking Layer Contracts to Rocket Lab and Northrop Grumman**
- Source: SatNews Publishers | 20251228T151744 | Bullish | Relevance: 100%
- The Space Development Agency (SDA) has awarded $1.6 billion in contracts to Rocket Lab and Northrop Grumman for the Tranche 3 Tracking Layer of the Proliferated Warfighter Space Architecture. These contracts will fund the construction and operation of 36 satellites to enhance the Pentagon's ability to detect and track advanced missile threats. Rocket Lab will receive $805 million for 18 satellites, marking its largest contract, while Northrop Grumman will receive $764 million for 18 satellites, adding to its extensive involvement in the PWSA.

**2. RTX Secures $104M ESSM Deal, Strengthens Global Missile Leadership**
- Source: The Globe and Mail | 20251229T140900 | Somewhat-Bullish | Relevance: 71%
- RTX Corporation's Raytheon segment secured a $104.1 million contract for technical and design agent engineering support for the Evolved SeaSparrow Missile (ESSM) and NATO SeaSparrow Missile Systems programs, with work set to complete by December 31, 2026. This deal, combining purchases for the U.S. Navy and other countries, underscores the global demand for RTX's combat-proven ESSM missile, a defense solution against high-speed anti-ship cruise missiles and other threats. The missile and missile defense systems market is projected to grow, benefiting RTX and other defense contractors like Northrop Grumman, Lockheed Martin, and Boeing.

**3. Lockheed Martin Stock (LMT) Today: Pentagon Contract Boosts, F‑35 Scrutiny, and Analyst Targets Ahead of Monday’s Open**
- Source: ts2.tech | 20251227T070758 | Neutral | Relevance: 64%
- Lockheed Martin (LMT) is experiencing a mixed sentiment with new Pentagon contract boosts for C-130J aircraft and a significant Space Development Agency award, reinforcing its backlog and cash flow. However, the company faces scrutiny over F-35 sustainment issues and analyst downgrades due to concerns about future cash flow and growth constraints. Investors are monitoring geopolitical headlines, program execution, and upcoming interest rate expectations ahead of the next market session and the Q1 earnings report.

**4. RTX stock sets up Monday: Fed minutes, Taiwan drills and the $185 line**
- Source: ts2.tech | 20251229T065842 | Somewhat-Bearish | Relevance: 61%
- RTX stock closed down on Friday at $185.17, with investors focusing on upcoming Fed minutes, year-end portfolio adjustments, and new geopolitical developments. China's live-fire drills around Taiwan have put defense contractors back in the spotlight, while traders also anticipate U.S. economic data and the potential for a "Santa Claus rally" before year-end. The company is set to report quarterly results on January 27, with the $185 stock price level being a key watch point for traders.

**5. Bar Harbor Wealth Management Sells 9,218 Shares of Exxon Mobil Corporation $XOM**
- Source: MarketBeat | 20251228T083759 | Neutral | Relevance: 59%
- Bar Harbor Wealth Management reduced its stake in Exxon Mobil by 4.1%, selling 9,218 shares and now holding 217,449 shares valued at $24.52 million. This position represents 1.5% of their portfolio and is their 15th largest holding. Concurrently, other institutional investors like Norges Bank and First Trust Advisors LP significantly increased their holdings in XOM, and Exxon Mobil also boosted its quarterly dividend to $1.03 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Alembic Global | $662 | $0 | 0% |
| 2025-12-12 | Citigroup | $654 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Alembic Global | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.76 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $82.7B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.76 |
| Forward P/E | 20.0 |
| Current P/E | 22.2 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.6% to 2.1% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.9pp (needs >4.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.73), confirming momentum. RSI neutral at 56. Volume at 34% of 20MA suggests lack of conviction. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.08% (CS: 78) | Neutral |
| RSI_14 | 55.8 | Neutral |
| MACD Histogram | 2.73 | Bullish |
| vs SMA20 | 1.025x | Above |
| vs SMA50 | 1.011x | Above |
| vs SMA200 | 1.063x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $577.87
- **Stop Loss:** $557.65 (3.5% risk)
- **Target:** $598.09 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 68
- **Position Value:** $39,295.16
- **Portfolio %:** 39.30%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*